SG11202110032TA - Small shedding blocking agents - Google Patents

Small shedding blocking agents

Info

Publication number
SG11202110032TA
SG11202110032TA SG11202110032TA SG11202110032TA SG11202110032TA SG 11202110032T A SG11202110032T A SG 11202110032TA SG 11202110032T A SG11202110032T A SG 11202110032TA SG 11202110032T A SG11202110032T A SG 11202110032TA SG 11202110032T A SG11202110032T A SG 11202110032TA
Authority
SG
Singapore
Prior art keywords
blocking agents
shedding
small
small shedding
blocking
Prior art date
Application number
SG11202110032TA
Inventor
Motti Hakim
Anna Fridman-Dror
Dror Alishekevitz
Edna Meilin
Ilana Mandel
Tehila Ben-Moshe
Avidor Shulman
Yair Sapir
Original Assignee
Biond Biologics Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biond Biologics Ltd filed Critical Biond Biologics Ltd
Publication of SG11202110032TA publication Critical patent/SG11202110032TA/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2803—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
    • C07K16/2818—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily against CD28 or CD152
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A61K2039/507—Comprising a combination of two or more separate antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/22—Immunoglobulins specific features characterized by taxonomic origin from camelids, e.g. camel, llama or dromedary
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
    • C07K2317/569—Single domain, e.g. dAb, sdAb, VHH, VNAR or nanobody®

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
SG11202110032TA 2019-03-14 2020-03-12 Small shedding blocking agents SG11202110032TA (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201962818351P 2019-03-14 2019-03-14
US201962942240P 2019-12-02 2019-12-02
US201962954802P 2019-12-30 2019-12-30
PCT/IL2020/050297 WO2020183473A1 (en) 2019-03-14 2020-03-12 Small shedding blocking agents

Publications (1)

Publication Number Publication Date
SG11202110032TA true SG11202110032TA (en) 2021-10-28

Family

ID=70334001

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11202110032TA SG11202110032TA (en) 2019-03-14 2020-03-12 Small shedding blocking agents

Country Status (11)

Country Link
US (1) US20220169732A1 (en)
EP (1) EP3938397A1 (en)
JP (1) JP2022525407A (en)
KR (1) KR20210141544A (en)
CN (1) CN113710704A (en)
AU (1) AU2020234111A1 (en)
BR (1) BR112021018205A2 (en)
CA (1) CA3130351A1 (en)
IL (1) IL286377A (en)
SG (1) SG11202110032TA (en)
WO (1) WO2020183473A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2021181396A1 (en) * 2020-03-12 2021-09-16 Biond Biologics Ltd. Shedding blocking agents with increased stability
IL311275A (en) * 2021-09-06 2024-05-01 Biond Biologics Ltd Cd28 shedding blocking agents

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4235871A (en) 1978-02-24 1980-11-25 Papahadjopoulos Demetrios P Method of encapsulating biologically active materials in lipid vesicles
US4501728A (en) 1983-01-06 1985-02-26 Technology Unlimited, Inc. Masking of liposomes from RES recognition
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
US4666828A (en) 1984-08-15 1987-05-19 The General Hospital Corporation Test for Huntington's disease
US5019369A (en) 1984-10-22 1991-05-28 Vestar, Inc. Method of targeting tumors in humans
US4683202A (en) 1985-03-28 1987-07-28 Cetus Corporation Process for amplifying nucleic acid sequences
US4801531A (en) 1985-04-17 1989-01-31 Biotechnology Research Partners, Ltd. Apo AI/CIII genomic polymorphisms predictive of atherosclerosis
US4837028A (en) 1986-12-24 1989-06-06 Liposome Technology, Inc. Liposomes with enhanced circulation time
US5272057A (en) 1988-10-14 1993-12-21 Georgetown University Method of detecting a predisposition to cancer by the use of restriction fragment length polymorphism of the gene for human poly (ADP-ribose) polymerase
US5464764A (en) 1989-08-22 1995-11-07 University Of Utah Research Foundation Positive-negative selection methods and vectors
US5192659A (en) 1989-08-25 1993-03-09 Genetype Ag Intron sequence analysis method for detection of adjacent and remote locus alleles as haplotypes
US5641870A (en) 1995-04-20 1997-06-24 Genentech, Inc. Low pH hydrophobic interaction chromatography for antibody purification
CN100509849C (en) * 2005-04-07 2009-07-08 苏州大学 Soluble human CD28 molecule detection kit and use thereof
WO2010009391A1 (en) * 2008-07-18 2010-01-21 Bristol-Myers Squibb Company Compositions monovalent for cd28 binding and methods of use
EP3765518A1 (en) * 2018-03-15 2021-01-20 Biond Biologics Ltd. Methods and compositions for decreasing soluble immune receptor cd28

Also Published As

Publication number Publication date
EP3938397A1 (en) 2022-01-19
CA3130351A1 (en) 2020-09-17
IL286377A (en) 2021-10-31
US20220169732A1 (en) 2022-06-02
KR20210141544A (en) 2021-11-23
JP2022525407A (en) 2022-05-13
AU2020234111A1 (en) 2021-10-14
BR112021018205A2 (en) 2021-12-28
CN113710704A (en) 2021-11-26
WO2020183473A1 (en) 2020-09-17

Similar Documents

Publication Publication Date Title
GB202005105D0 (en) n
CA190078S (en) Case
GB201814169D0 (en) Blockchain autonoumous agents
CA194649S (en) Shed
CA188243S (en) Shed
CA188241S (en) Shed
CA188242S (en) Shed
IL289569A (en) Garment
IL286377A (en) Small shedding blocking agents
GB201906668D0 (en) Antibacterial agents
CA185994S (en) One-piece garment
CA185995S (en) One-piece garment
GB2591218B (en) Garment
GB2575149B (en) Lanyards
CA185991S (en) One-piece garment
CA185993S (en) One-piece garment
GB2600565B (en) Garment
GB202002530D0 (en) N
EP3805508C0 (en) Blocking
EP3827189C0 (en) Blocking means
CA195219S (en) Overall
CA189432S (en) Case
CA189431S (en) Case
CA185992S (en) One-piece garment
CA204103S (en) Shuttle